Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 11, 2004, Pages 5369-5376

  Biermasz, Nienke R ^a   Van Thiel, Sjoerd W ^a   Pereira, Alberto M ^a   Hoftijzer, Hendrieke C ^a   Van Hemert, Albert M ^b   Smit, Jan W A ^a   Romijn, Johannes A ^a   Roelfsema, Ferdinand ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b PARNASSIA PSYCHIATRIC INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; GROWTH HORMONE; OCTREOTIDE;

ACROMEGALY; ADULT; AGE; AGED; ANXIETY; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE DURATION; FATIGUE; FEMALE; HUMAN; HYPOPITUITARISM; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REMISSION; SEX DIFFERENCE; SOCIAL ISOLATION; TRANSSPHENOIDAL SURGERY;

ACROMEGALY; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; REGRESSION ANALYSIS;

EID: 8744276605     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0669     Document Type: Article

References (29)

1. Biermasz NR, van Dulken H, Roelfsema F 2000 Ten-year follow-up results of transsphenoidal microsurgery in actomegaly. J Clin Endocrinol Metab 85: 4596-4602
2. Beauregard C, Truong U, Hardy J, Serri O 2003 Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly. Clin Endocrinol (Oxf) 58:86-91
3. Swearingen B, Barker FG, Katznelson L, Biller BM, Grinspoon S, Klibanski A, Moayeri N, Black PM, Zervas NT 1998 Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 83:3419-3426
4. Biermasz NR, Dekker FW, Pereira AM, Van Thiel SW, Schutte PJ, van Dulken H, Romijn JA, Roelfsema F 2004 Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements. J Clin Endocrinol Metab 89:2789-2796
5. Bates AS, Van't Hoff W, Jones JM, Clayton RN 1993 An audit of outcome of treatment in acromegaly. Q J Med 86:293-299
6. Webb SM, Prieto L, Badia X, Albareda M, Catala M, Gaztambide S, Lucas T, Paramo C, Pico A, Lucas A, Halperin I, Obiols G, Astorga R 2002 Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties. Clin Endocrinol (Oxf) 57:251-258
7. Ware Jr JE, Sherbourne CD 1992 The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473-483
8. Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T, Westlake L 1992 Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 305:160-164
9. VanderZee KI, Sanderman R, Heyink J 1996 A comparison of two multidimensional measures of health status: the Nottingham Health Profile and the RAND 36-Item Health Survey 1.0. Qual Life Res 5:165-174
10. Van der Zee KI, Sanderman R 1992 Het meten van de algemene gezondheidstoestand met de RAND-36, een handleiding. Noordelijk Centrum voor Gezondheidsvraagstukken, Groningen, The Netherlands: Rijks Universiteit Groningen, 1-28
11. Hunt SM, McKenna SP, McEwen J, Backett EM, Williams J, Papp E 1980 A quantitative approach to perceived health status: a validation study. J Epidemiol Community Health 34:281-286
12. Hunt SM, McEwen J 1980 The development of a subjective health indicator. Sociol Health Illn 2:231-246
13. Hinz A, Klaiberg A, Schumacher J, Brahler E 2003 The psychometric quality of the Nottingham Health Profile (NHP) in the general population. Psychother Psychosom Med Psychol 53:353-358
14. Smets EM, Garssen B, Bonke B, De Haes JC 1995 The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39:315-325
15. Smets EM, Visser MR, Willems-Groot AF, Garssen B, Schuster-Uitterhoeve AL, De Haes JC 1998 Fatigue and radiotherapy: (B) experience in patients 9 months following treatment. Br J Cancer 78:907-912
16. Zigmond AS, Snaith RP 1983 The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361-370
17. Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM 1997 A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 27:363-370
18. Janssen YJ, Frolich M, Roelfsema F 1997 A low starring dose of genotropin in growth hormone-deficient adults. J Clin Endocrinol Metab 82:129-135
19. Fava GA, Sonino N, Morphy MA 1993 Psychosomatic view of endocrine disorders. Psychother Psychosom 59:20-33
20. Furman K, Ezzat S 1998 Psychological features of acromegaly. Psychother Psychosom 67:147-153
21. Sonino N, Scarpa E, Paoletta A, Fallo F, Boscaro M 1999 Slow-release lanreotide treatment in acromegaly: effects on quality of life. Psychother Psychosom 68:165-167
22. Deyneli O, Yavuz D, Gozu H, Aydin H, Bicer D, Topcuoglu V, Akalin SN, Evaluation of quality of life in turkish patients with acromegaly. Proc of the 84th Annual Meeting of The Endocrine Society, Philadelphia, PA, 2003, P3-508 (Abstract)
23. McMillan CV, Bradley C, Gibney J, Russell-Jones DL, Sonksen PH 2003 Evaluation of two health status measures in adults with growth hormone deficiency. Clin Endocrinol (Oxf) 58:436-445
24. Johnson MD, Woodburn CJ, Vance ML, Patient perception of effects of pituitary disease. Proc of the 83th Annual Meeting of The Endocrine Society, San Francisco, CA, 2002, P3-625 (Abstract)
25. Page RC, Hammersley MS, Burke CW, Wass JA 1997 An account of the quality of life of patients after treatment for non-functioning pituitary tumours. Clin Endocrinol (Oxf) 46:401-406
26. Kroenke K, Jackson JL, Chamberlin J 1997 Depressive and anxiety disorders in patients presenting with physical complaints: clinical predictors and outcome. Am J Med 103:339-347
27. Schneider HJ, Pagotto U, Stalla GK 2003 Central effects of the somatotropic system. Eur J Endocrinol 149:377-392
28. McMillan CV, Bradley C, Gibney J, Healy ML, Russell-Jones DL, Sonksen PH 2003 Psychological effects of withdrawal of growth hormone therapy from adults with growth hormone deficiency. Clin Endocrinol (Oxf) 59:467-475
29. Hochberg Z, Pacak K, Chrousos GP 2003 Endocrine withdrawal syndromes. Endocr Rev 24:523-538